As drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more cases linking them to ...

Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...

ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch applied to the skin. One day, researchers want to use switches of this kind ...

The U.S. District Court for the Eastern District of Pennsylvania concluded the plaintiff, who has Type 1 diabetes and tracks ...

Motorists could be slapped with fines of up to £1,000 if they fail to tell the DVLA about certain health conditions that ...

The claim that coriander seeds can cure high blood sugar in 24 hours is false. The viral video is AI-generated and falsely ...

This CGM will track your body's response - Could personalised glucose data inform your body’s metabolism and performance?

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications needed to control their blood sugar, U.S. health officials warned.

Continuous glucose monitors are small devices that use a sensor under the skin to measure blood sugar, sending regular ...